Benjamin Esque, Corstasis Therapeutics - New Nasal Diuretic | LSI USA ‘24

Corstasis Therapeutics is a pivotal stage drug development company improving the utility of commonly used therapeutics for Heart Failure, Liver and Kidney disease.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow